- metformin og et sulfonylurinstof, til patienter (særligt overvægtige patienter) med insufficient
as triple oral therapy in combination with – metformin and a sulphonylurea, in patients (particularly overweight patients) with insufficient glycaemic control despite dual oral therapy (see section 4.4).